Retinal detachment and proliferative vitreoretinopathy

Developments in Ophthalmology

Volumn 55, Issue , 2015, Pages 154-162

  Kwon, Oh Woong ^a   Song, Ji Hun ^b   Roh, Mi In ^c  

^a NUNE Eye Hospital   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOTHERAPY; HUMAN; PATHOPHYSIOLOGY; RETINAL DETACHMENT; RISK FACTOR; SCLERA BUCKLING PROCEDURE; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE;

CRYOTHERAPY; HUMANS; RETINAL DETACHMENT; RISK FACTORS; SCLERAL BUCKLING; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE;

EID: 84947262898     PISSN: 02503751     EISSN: 16622790     Source Type: Book Series    
DOI: 10.1159/000438972     Document Type: Article

References (47)

1. Moysidis SN, Thanos A, Vavvas DG: Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside. Mediators Inflamm 2012; 2012:815937.
2. Van de Put MA, Hooymans JM, Los LI: The incidence of rhegmatogenous retinal detachment in The Netherlands. Ophthalmology 2013; 120:616-622.
3. Laatikainen L, Tolppanen EM, Harju H: Epidemiology of rhegmatogenous retinal detachment in a Finnish population. Acta Ophthalmol 1985; 63:59-64.
4. Mitry D, Charteris DG, Yorston D, Siddiqui MA, Campbell H, Murphy AL, Fleck BW, Wright AF, Singh J; Scottish RD Study Group: The epidemiology and socioeconomic associations of retinal detachment in Scotland: a two-year prospective population-based study. Invest Ophthalmol Vis Sci 2010; 51:4963-4968.
5. Haimann MH, Burton TC, Brown CK: Epidemiology of retinal detachment. Arch Ophthalmol 1982; 100:289-292.
6. Park SJ, Choi NK, Park KH, Woo SJ: Five year nationwide incidence of rhegmatogenous retinal detachment requiring surgery in Korea. PLoS One 2013; 8:e80174.
7. Ivanisevic M, Bojic L, Eterovic D: Epidemiological study of nontraumatic phakic rhegmatogenous retinal detachment. Ophthalmic Res 2009; 32:237-239.
8. Ramos M, Kruger EF, Lashkari K: Biostatistical analysis of pseudophakic and aphakic retinal detachments. Semin Ophthalmol 2002; 17:206-213.
9. Erie JC, Raecker ME, Baratz KH, Schleck CD, Robertson DM: Risk of retinal detachment after cataract extraction, 1980-2004: a population-based study. Trans Am Ophthalmol Soc 2006; 104:167-175.
10. Bhagwandien AC, Cheng YY, Wolfs RC, van Meurs JC, Luyten GP: Relationship between retinal detachment and biometry in 4,262 cataractous eyes. Ophthalmology 2006; 113:643-649.
11. Tuft SJ, Minassian D, Sullivan P: Risk factors for retinal detachment after cataract surgery: a case-control study. Ophthalmology 2006; 113:650-656.
12. Jakobsson G, Montan P, Zetterberg M, Stenevi U, Behndig A, Lundström M: Capsule complication during cataract surgery: retinal detachment after cataract surgery with capsule complication: Swedish Capsule Rupture Study Group report 4. J Cataract Refract Surg 2009; 35:1699-1705.
13. Colin J, Robinet A, Cochener B: Retinal detachment after clear lens extraction for high myopia: seven-year follow-up. Ophthalmology 1999; 106:2281-2284.
14. Alio JL, Ruiz-Moreno JM, Shabayek MH, Lugo FL, Abd El Rahman AM: The risk of retinal detachment in high myopia after small incision coaxial phacoemulsification. Am J Ophthalmol 2007; 144:93-98.
15. Stryjewski TP, Andreoli CM, Eliott D: Retinal detachment after open globe injury. Ophthalmology 2014; 121:327-333.
16. Jahn CE, Richter J, Jahn AH, Kremer G, Kron M: Pseudophakic retinal detachment after uneventful phacoemulsification and subsequent neodymium:YAG capsulotomy for capsule opacification. J Cataract Refract Surg 2003; 29:925-929.
17. Ranta P, Tommila P, Kivela T: Retinal breaks and detachment after neodymium:YAG laser posterior capsulotomy: five-year incidence in a prospective cohort. J Cataract Refract Surg 2004; 30:58-66.
18. Weinberg DV, Lyon AT, Greenwald MJ, Mets MB: Rhegmatogenous retinal detachments in children: risk factors and surgical outcomes. Ophthalmology 2003; 110:1708-1713.
19. Wang NK, Tsai CH, Chen YP, Yeung L, Wu WC, Chen TL, Lin KK, Lai CC: Pediatric rhegmatogenous retinal detachment in East Asians. Ophthalmology 2005; 112:1890-1895.
20. Wiedemann P, Weller M: The pathophysiology of proliferative vitreoretinopathy. Acta Ophthalmol Suppl 1988; 189:3-15.
21. Casaroli Marano RP, Vilaro S: The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1994; 35:2791-803.
22. Baudouin C, Hofman P, Brignole F, Bayle J, Loubiè re R, Gastaud P: Immunocytology of cellular components in vitreous and subretinal fluid from patients with proliferative vitreoretinopathy. Ophthalmologica 1991; 203:38-46.
23. Lee SC, Kwon OW, Seong GJ, Kim SH, Ahn JE, Kay ED: Epitheliomesenchymal transdifferentiation of cultured RPE cells. Ophthalmic Res 2001; 33:80-86.
24. Hiscott P, Sheridan C, Magee RM, Grierson I: Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res 1999; 18:167-190.
25. Jerdan JA, Pepose JS, Michels RG, Hayashi H, de Bustros S, Sebag M, Glaser BM: Proliferative vitreoretinopathy membranes. An immunohistochemical study. Ophthalmology 1989; 96:801-810.
26. Nagasaki H, Shinagawa K, Mochizuki M: Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res 1998; 17:77-98.
27. Charteris DG, Sethi CS, Lewis GP, Fisher SK: Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology. Eye 2002; 16:369-374.
28. Bonnet M, Guenoun S: Surgical risk factors for severe postoperative proliferative vitreoretinopathy (PVR) in retinal detachment with grade B PVR. Graefes Arch Clin Exp Ophthalmol 1995; 233:789-791.
29. Jaccoma EH, Conway BP, Campochiaro PA: Cryotherapy causes extensive breakdown of the blood-retinal barrier. A comparison with argon laser photocoagulation. Arch Ophthalmol 1985; 103:1728-1730.
30. Schwartz SG, Flynn HW: Primary retinal detachment: scleral buckle or pars plana vitrectomy? Curr Opin Ophthalmol 2006; 17:245-250.
31. Iverson DA, Ward TG, Blumenkranz MS: Indications and results of relaxing retinotomy. Ophthalmology 1990; 97:1298-1304.
32. Federman JL, Eagle RC Jr: Extensive peripheral retinectomy combined with posterior 360 degrees retinotomy for retinal reattachment in advanced proliferative vitreoretinopathy cases. Ophthalmology 1990; 97:1305-1320.
33. Saw SM, Gazzard G, Wagle AM, Lim J, Au Eong KG: An evidence-based analysis of surgical interventions for uncomplicated rhegmatogenous retinal detachment. Acta Ophthalmol Scand 2006; 84:606-612.
34. Tornambe PE, Hilton GF, Brinton DA, Flood TP, Green S, Grizzard WS, Hammer ME, Leff SR, Masciulli L, Morgan CM: Pneumatic retinopexy. A two-year follow-up study of the multicenter clinical trial comparing pneumatic retinopexy with scleral buckling. Ophthalmology 1991; 98:1115-1123.
35. Ahmadieh H, Moradian S, Faghihi H, Parvaresh MM, Ghanbari H, Mehryar M, Heidari E, Behboudi H, Banaee T, Golestan B; Pseudophakic and Aphakic Retinal Detachment (PARD) Study Group: Anatomic and visual outcomes of scleral buckling versus primary vitrectomy in pseudophakic and aphakic retinal detachment: six-month follow-up results of a single operation-report no. 1. Ophthalmology 2005; 112:1421-1429.
36. Brazitikos PD, Androudi S, Christen WG, Stangos NT: Primary pars plana vitrectomy versus scleral buckle surgery for the treatment of pseudophakic retinal detachment: a randomized clinical trial. Retina 2005; 25:957-964.
37. Wolfensberger TJ: Foveal reattachment after macula-off retinal detachment occurs faster after vitrectomy than after buckle surgery. Ophthalmology 2004; 111:1340-1343.
38. Chang S, Coleman DJ, Lincoff H, Wilcox LM Jr, Braunstein RA, Maisel JM: Perfluoropropane gas in the management of proliferative vitreoretinopathy. Am J Ophthalmol 1984; 98:180-188.
39. Sell CH, McCuen BW 2nd, Landers MB 3rd, Machemer R: Long-Derm results of successful vitrectomy with silicone oil for advanced proliferative vitreoretinopathy. Am J Ophthalmol 1987; 103:24-28.
40. Sun JK, Arroyo JG: Adjunctive therapies for proliferative vitreoretinopathy. Int Ophthalmol Clin 2004; 44:1-10.
41. Wiedemann P, Hilgers RD, Bauer P, Heimann K: Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol 1998; 126:550-559.
42. Shinohara K, Tanaka M, Sakuma T, Kobayashi Y: Efficacy of daunorubicin encapsulated in liposome for the treatment of proliferative vitreoretinopathy. Ophthalmic Surg Lasers Imaging 2003; 34:299-305.
43. Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT, Aylward GW: Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: results from a randomized, double-blind, controlled clinical trial. Ophthalmology 2001; 108:1179-1183.
44. Wickham L, Bunce C, Wong D, McGurn D, Charteris DG: Randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy. Ophthalmology 2007; 114:698-704.
45. Garcia RA, Sanchez JG, Arevalo JF: Combined 5-fluorouracil, low-molecular-weight heparin, and silicone oil in the management of complicated retinal detachment with proliferative vitreoretinopathy grade C. Ophthalmic Surg Lasers Imaging 2007; 38:276-282.
46. Pennock S, Rheaume MA, Mukai S, Kazlauskas A: A novel strategy to develop therapeutic approaches to prevent proliferative vitreoretinopathy. Am J Pathol 2011; 179:2931-2940.
47. Lei H, Rhéaume MA, Velez G, Mukai S, Kazlauskas A: Expression of PDGFRα is a determinant of the PVR potential of ARPE19 cells. Invest Ophthalmol Vis Sci 2011; 52:5016-5021.